Mr. Nikolchev joined Cardica in October 2015. Previously, he served as founder, CEO and chief technology officer of Pivot Medical (now part of Stryker Sports Medicine) where he directed the transition from development enterprise to a full commercial organization with the leading brand in the fastest growing orthopedic market segment. He joined Pivot Medical while serving as a venture partner at Frazier Healthcare Ventures. Before Frazier, he served as founder, president and CEO of CardioMind (sold to Biosensors International) and previously as president and CEO of Pro*Duct Health (sold to Cytyc). Prior to Pro*Duct Health, he served as manager of the new venture group at Target Therapeutics, where he subsequently founded Conceptus (sold to Bayer AG in 2014) and served as founder and chief technology officer for many years. Prior to his tenure leading medical device companies, Mr. Nikolchev served in a variety of escalating management positions within engineering organizations. He holds B.S. and M.S. degrees in Mechanical Engineering from Stanford University and a M.S. degree in Management of Technology from the Massachusetts Institute of Technology. He is the author of numerous papers on technology commercialization and new technology development and an inventor and co-inventor on more than 35 issued or pending patents.